Skip to main content
HR 8540 117th Congress House Health

Developing and Nationalizing Key Cannabis Research Act of 2022

Introduced: July 27, 2022 Introduced by: Peters, Scott H. Democratic · California See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Nov 1, 2022
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Jul 27, 2022
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jul 27, 2022
Introduced in House
 Plain-English summary Congressional Research Service

Developing and Nationalizing Key Cannabis Research Act of 2022

This bill directs the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) to expand activities concerning cannabis research.

The NIH must collaborate with specified agencies to develop a national cannabis research agenda. Among other topics, the agenda must address (1) the therapeutic benefits of cannabis, (2) how cannabis effects specified populations, and (3) other public safety considerations. Additionally, the NIH must designate centers of excellence in cannabis research at institutions of higher education to conduct interdisciplinary research about biomedical, behavioral, and social issues related to cannabis.

The CDC must work with other agencies to collect population-wide data about cannabis use, including (1) demographic factors, (2) health outcomes, (3) product variety, and (4) other relevant health information.

What's happening now November 1, 2022

Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.

 Committees of jurisdiction 3
 Cosponsors 1
All 1 Republican 1